Literature DB >> 16865652

[Diagnostic difficulties in encephalitis and glioma].

S Parbel1, S Vlaho, B Gebhardt, L Porto, E Hattingen, T Klingebiel, H Böhles, M Kieslich.   

Abstract

BACKGROUND: Glial neoplasms can infiltrate the central nervous system extensively with relative preservation of the underlying neuronal architecture. The differential diagnosis between cerebral glioma and infective lesions can be very difficult to distinguish by MRI only. CASE REPORT: We report a 7 year old boy with recurrent vomiting, fever, weakness, abdominal pain and diarrhea. Besides an expressive speech disturbance the neurological examination showed no pathological findings. The sonography revealed discrete hepatomegaly and small pericardial effusion. MRI showed a diffuse mesencephalic and pontine swelling without contrast medium enhancement possibly pointing to an infective lesion. Microbiological, serological and metabolic investigations of blood and CSF were normal. After initial improvement associated with antibiotic, antiviral and dexamethasone treatment the process relapsed progessively. The 1H-MR-spectroscopy showed elevated cholin and decreased N-acetyl-aspartate levels suspicious for a proliferating process. Brain biopsy revealed anaplastic astrocytoma (WHO III). Despite of radiation and chemotherapy the tumordisease deteriorated and the patient died because of progressive brainstem infiltration one year later.
CONCLUSION: This case report shows that cerebral glioma can mimick infective brain disease and that MR-spectroscopy is an important non-invasive tool in this differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865652     DOI: 10.1055/s-2006-933521

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  1 in total

1.  Area postrema syndrome as frequent feature of Bickerstaff brainstem encephalitis.

Authors:  Pia S Zeiner; Annemarie Brandhofe; Monika Müller-Eschner; Helmuth Steinmetz; Waltraud Pfeilschifter
Journal:  Ann Clin Transl Neurol       Date:  2018-10-31       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.